Women's health and clinical trials

Journal of Clinical Investigation

Volumn 112, Issue 7, 2003, Pages 973-977

  Schiebinger, Londa ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; PARACETAMOL;

AGING; ALCOHOLISM; ANXIETY DISORDER; AUTOIMMUNE DISEASE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; DRUG METABOLISM; DRUG USE; EPILEPSY; FEMALE; FOOD AND DRUG ADMINISTRATION; GENDER; HEALTH; HUMAN; MEDICAL RESEARCH; MODEL; MUSCLE SPASM; OCCUPATIONAL HEALTH; PAIN; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; ARTICLE; CLINICAL TRIAL; WOMEN'S HEALTH;

CLINICAL TRIALS; FEMALE; HUMANS; WOMEN'S HEALTH;

EID: 0242380326     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319993     Document Type: Review

References (28)

1. Healy, B. 1991. Women's health, public welfare. JAMA. 266:566-568.
2. 1989. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N. Engl. J. Med. 321:129-135.
3. 1982. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 248:1465-1477.
4. Shock, N.W., et al. 1984. Normal human aging: the Baltimore Longitudinal Study of Aging. NIH Publication no. 84-2450. Washington, DC, USA. 399 pp.
5. Rosser, S. 1994. Women's health: missing from U.S. medicine. Indiana University Press. Bloomington, Indiana, USA. 213 pp.
6. Dawber, T.R., Meadors, G.F., and Moore, F.E.J. 1951. Epidemiological approaches to heart disease: the Framingham Study. Am. J. Public Health. 41:279-286.
7. Johnson, T., and Fee, E. 1997. Women's health research. In Women's health research: a medical and policy primer. F. Haseltine and B. Jacobson, editors. Health Press International. Washington, DC, USA. 3-26.
8. Sherman, L.A., Temple, R., and Merkatz, R.B. 1995. Women in clinical trials: an FDA perspective. Science. 269:793-795.
9. US General Accounting Office, Women's health: FDA needs to ensure more study of gender differences in prescription drug testing, 1992, GAO/HRD-93-17.
10. Merkatz, R., et al. 1993. Women in clinical trials of new drugs. N. Engl. J. Med. 329:292-296.
11. 1991. Gender disparities in clinical decision making. Council on Ethical and Judicial Affairs, American Medical Association. JAMA. 266:559-562.
12. Nechas, E., and Foley, D. 1994. Unequal treatment: what you don't know about how women are mistreated by the medical community. Simon & Schuster Inc. New York, New York, USA. 272 pp.
13. Johnson, T., and Fee, E. 1994. Women's participation in clinical research: from protectionism to access. In Women and health research: ethical and legal issues of including women in clinical studies. Volume 2. A. Mastroianni, R. Faden, and D. Federman, editors. National Academy Press. Washington, DC, USA. 1-10.
14. Norsigian, J. 1993. Women and national health care reform: a progressive feminist agenda. J. Women's Health (Larchmt.). 2:91-94.
15. Ruzek, S., Olesen, V., and Clarke, A., editors. 1997. Women's health: complexities and differences. Ohio State University Press. Columbus, Ohio, USA. 689 pp.
16. Doyal, L. 1995. What makes women sick: gender and the political economy of health. Rutgers University Press. New Brunswick, New Jersey, USA. 280 pp.
17. Gamble, V., and Blustein, B. 1994. Racial differentials in medical care. In Women and health research: ethical and legal issues of including women in clinical studies. Volume 2. A. Mastroianni, R. Faden, and D. Federman, editors. National Academy Press. Washington, DC, USA. 174-191.
18. National Institutes of Health Revitalization Act of 1993. Public Law 103-43. June 10.
19. Notice of the "NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research." 1994. Federal record. 59(Part VIII):14508-14513.
20. NIH Department of Heath and Human Services. 2000. Monitoring adherence to the NIH policy on the inclusion of women and minorities. 103 pp.
21. Primmer, L. 1997. Women's health research. Congressional action and legislative gains: 1990-1994. In Women's health research: a medical and policy primer. F. Haseltine and B. Jacobson, editors. Health Press International. Washington, DC, USA. 301-330.
22. st century. Volume 1, Executive summary. National Institutes of Health. Bethesda, Maryland, USA. 137 pp.
23. Merkatz, R., and Summers, E. 1997. Including women in clinical trials: policy changes at the Food and Drug Administration. In Women's health research: a medical and policy primer. F. Haseltine and B. Jacobson, editors. Health Press International. Washington, DC, USA. 265-284.
24. Institute of Medicine (U.S.), Committee on Understanding the Biology of Sex and Gender Differences. 2001. Exploring the biological contributions to human health: does sex matter? National Academy Press. Washington, DC, USA. 267 pp.
25. Haseltine, F. 1997. Foreword. In Women's health research: a medical and policy primer. F. Haseltine and B. Jacobson, editors. Health Press. Washington, DC, USA. xiii-xviii.
26. Holden, C. 1997. Women not shortchanged in trials? Science. 275:1571-1573.
27. Krieger, N., and Fee, E. 1994. Women's health, politics, and power: essays on sex/gender, medicine, and public health. N. Krieger and E. Fee, editors. Baywood Publishing Co. Amityville, New York, USA. 376 pp.
28. Schiebinger, L. 1999. Has feminism changed science? Harvard University Press. Cambridge, Massachusetts, USA. 252 pp.